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SUMMARY
In the present study, the effect of treatment with granulocyte colony-stimulating factor (G-CSF)
on cellular composition of the bone marrow and the number of circulating leucocytes of
granulocytopenic mice, whether or not infected with Staphylococcus aureus, was assessed. With
two monoclonal antibodies, six morphologically distinct cell populations in the bone marrow
could be characterised and quantitated by two-dimensional flow cytometry. Granulocytopenia
was induced by cyclophosphamide or sublethal irradiation. Cyclophosphamide predominantly
affected the later stages of dividing cells in the bone marrow resulting in a decrease in number of
granulocytic cells, monocytic cells, lymphoid cells and myeloid blasts. G-CSF administration to
cyclophosphamide-treated mice increased the number of early blasts, myeloid blasts and granulo-
cytic cells in the bone marrow, which indicates that this growth factor stimulates the proliferation
of these cells in the bone marrow. During infection in cyclophosphamide-treated mice the number
of myeloid blasts increased. However, when an infection was induced in cyclophosphamide and
G-CSF-treated mice, the proliferation of bone-marrow cells was not changed compared to that
in noninfected similarly treated mice. Sublethal irradiation affected all bone-marrow cell popu-
lations, including the early blasts. G-CSF-treatment of irradiated mice increased only the number
of myeloid blasts slightly, whereas an infection in irradiated mice, whether or not treated with
G-CSF, did not affect the number of bone-marrow cells. Together, these studies demonstrated
that irradiation affects the early blasts and myeloid blasts in the bone marrow more severely than
treatment with cyclophosphamide. Irradiation probably depletes the bone marrow from G-CSF-
responsive cells, while cyclophosphamide spared G-CSF responsive cells, thus enabling the
enhanced G-CSF-mediated recovery after cyclophosphamide treatment. Only in these mice, bone
marrow recovery is followed by a strong mobilisation of mature granulocytes and their band
forms from the bone marrow into the circulation during a bacterial infection.
INTRODUCTION of granulocytes in the circulation, granulocytopenic patients
are treated nowadays with recombinant granulocyte colony-
Both radiotherapy and chemotherapy, used for treating neo-
stimulating factor (G-CSF).2,3
plastic disorders, can suppress the haematopoietic activity of Earlier we developed a mouse model, that in a certain way
the bone marrow, that induces leucocytopenia, particularly mimics the effect of prophylactic G-CSF treatment of granulo-
granulocytopenia. The clinical benefit of accelerated recovery cytopenic patients to prevent infection. Using this model, we
from granulocytopenia is a reduction of infectious compli- reported recently that the effect of G-CSF treatment on the
cations, as granulocytes play an essential role in host defence increase in the number of granulocytes in the circulation of
against bacterial and fungal infections.1 To increase the number granulocytopenic mice and on the course of bacterial infection
in these mice, is dependent on the cause of granulocytopenia.4
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The bone marrow contains cells of various lineages in a Quantitation of the number of circulating leucocytes
Blood samples were collected in plastic cups containing hep-variety of stages of cell differentiation and maturation.
Advances in two-dimensional flow cytometry allows character- arin. The numbers of leucocytes were counted in a Bürker
haemocytometer and the number of granulocytes was deter-isation and quantitation of these cell populations.5,6 With the
use of two recently described monoclonal antibodies, murine mined by differential count of 200 leucocytes in two Giemsa-
stained blood smears.bone-marrow cells can be separated into at least six morpho-
logically distinct cell populations with a relatively high homo-
geneity, on the basis of the intensity of antigen expression.7 Quantitation of the number of bone-marrow cells
At different time-points before and after infection, mice wereThis method has shown to be a reliable and efficient tool for
monitoring the composition of cell populations in the bone killed and both femurs were removed. The epiphyses were cut
off and the marrow was collected by flushing the shafts withmarrow of Listerial monocytogenes-infected mice8 and has also
been used in a study of bone-marrow cells from granulocytop- 2 ml of RPMI medium (Flow Laboratories, Rockville, MD)
supplemented with 100 U/ml penicillin G and 50 mg/ml strepto-enic mice.9
The aim of the present study was to assess the effect of mycin; then the cells were dispersed into a single cell sus-
pension. The number of cells were counted in a BürkerG-CSF on the various cell lineages in the bone marrow of
mice which have been rendered granulocytopenic by cyclophos- haemocytometer using Türk’s solution and the number of
bone-marrow cells per mouse was calculated under the assump-phamide or sublethal body irradiation and were infected with
Staphylococcus aureus. In addition, the effect of G-CSF on the tion that two femurs contain 11·8% of the total murine bone
marrow.10 From freshly isolated bone-marrow cells, themobilisation of granulocytes into the circulation of infected
mice has been studied. erythrocytes were lysed by incubating the cells with lysis buffer
(0·2  NH4Cl, 0·01  KHCO3 and 0·1  ethylenediamine tetra-
acetic acid (EDTA)) for 5 min at RT and washed three timesMATERIALS AND METHODS
with phosphate buffered saline (PBS).
Animals
Specific pathogen-free female C57Bl/6 mice weighing 20 g, Antibodies and conjugates
purchased from IFFA Credo, Saint Germaine-sur-L’Abresle, The purified monoclonal antibodies (mAb) used in this study
France, were used. Sterilised food and tap water were given were ER-MP12 (anti-CD31)4 and ER-MP20 (anti-Ly-6C).4
ad libitum. ER-MP12 was conjugated to biotin (N-hydroxysuccini-
midobiotin, Boehringer Mannheim GMBH, Mannheim,Induction of granulocytopenia
Germany) (ER-MP12-bio+) and ER-MP20 was conjugatedSublethal granulocytopenia was induced by single subcutane-
to fluorescein isothiocyanate, isomer I (Sigma Chemical Co.,ous (s.c.) injection of 250 mg/kg bodyweight cyclophospham-
St. Louis, MO) (ER-MP20-FITC ). As a second stage fluo-ide (Endoxan; Asta Medica B.V., Diemen, The Netherlands)
rescent reagent R-phycoerythrin-conjugated streptavidinor by sublethal total body irradiation. The animals, placed in
(SAv-PE) (Pharmingen, San Diego, CA) was used, whichplexiglass containers, received a total of 5 Gy from a 137Cs
binds to ER-MP12-bio+.gamma cell irradiator (Philips SL-75–5/6 MV linear acceler-
ator, Philips Medical Systems, Best, The Netherlands) in the
Flow cytometryposterior–anterior and anterior–posterior directions. Both
For phenotyping 5×105 bone-marrow cells from each mousemethods induced the same degree of granulocytopenia (sub-
were labelled with an optimal concentration of ER-lethally) in C57Bl/6 mice.
MP12-bio+ in PBS supplemented with 1% bovine serum
albumin (PBS–BSA) for 30 min at 4°, and then washed threeMicroorganisms
times with PBS–BSA. Next, the cells were incubated withVirulent serum-resistant S. aureus (ATCC 25923) were stored
optimal concentrations of both ER-MP20-FITC and SAv-PEin tryptose phosphate broth (TPB) (Oxoid Ltd, Basingstoke,
simultaneously during 30 min at 4°. After washing the cellsUK) supplemented with 10% dimethyl sulphoxide (DMSO)
three times with PBS–BSA, phenotypic analysis was performedat −70°. Samples of the frozen stock were cultured for 18 hr
with a FACScan@ cytofluorimeter (Becton Dickinson,at 37° in TPB. Bacteria were collected by centrifugation
Sunnyvale, CA). To determine background fluorescence, cells(10 min; 900 g), washed twice in phosphate-buffered saline
were incubated with PBS–BSA or only one of the mAbs.(PBS) and suspended at appropriate bacterial concentrations
In each experiment, bone-marrow cells from naive micein pyrogen-free saline. The virulence of the bacteria was
were used to determine the fluorescence windows that dis-maintained by repeated passage through mice.
tinguish six cell populations and these windows were used to
gate the cell populations in the bone marrow of mice underExperimental design
After induction of granulocytopenia on day 0, mice immedi- study. The relative size of the various cell populations and the
total numbers of bone-marrow cells per mouse were used toately received s.c. injections of 5 mg purified recombinant
human G-CSF (rhG-CSF ) (Neupogen, Amgen B.V., Breda, calculate the number of cells of each cell population in the
bone marrow of each mouse.The Netherlands) twice a day during 4 days. On day 4 of the
experiment, the mice were infected intramuscularly (i.m.) with
5×106 S. aureus into the right thigh muscle. After various Nomenclature of bone-marrow cell populations
In accordance with previous studies6,7 in naive mice, six celltime intervals blood was taken by puncture of the orbital
venous sinus, the animals were killed by CO2 asphyxiation populations could be defined as summarized in Table 1. The
intensity of antigen expression of ER-MP12 and ER-MP20 isand both femurs were removed.
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Table 1. Bone-marrow cell populations of naive mice defined on the basis of binding of the
monoclonal antibodies ER-MP12 and ER-MP20
Cell population ER-MP12 ER-MP20 FACS window in Fig. 1(a)
Early blasts* hi − 1
Myeloid blasts† + + 2
Granulocytic cells‡ − med 3
Monocytic cells§ − hi 4
Lymphoid cells¶ med − 5
Erythroid cells** − − 6
Expression measured by FACS-analysis, hi=high expression; med=mediate expression;
+=both high and mediate expression; −=negative expression of ER-MP12 or ER-MP20.
*ER-MP12hi ER-MP20− population consists of morphologically undifferentiated blasts
and recognizable blasts of the myeloid, erythroid and lymphoid lineages.
†ER-MP12+ ER-MP20+ population the myeloid blast population (ER-MP12+ ER-
MP20+) contains primarily myeloid blasts, either morphologically undifferentiated or reco-
gnizable as such; the vast majority of these cells expresses the myeloid marker Gr-1
(unpublished data).
‡ER-MP12− ER-MP20med population is highly enriched for immature and mature
granulocytic cells.
§ER-MP12− ER-MP20hi population consists of mainly immature and mature mono-
cytic cells.
¶ER-MP12med ER-MP20− contains predominantly mature lymphoid cells and a few
undifferentiated blasts.
**ER-MP12− ER-MP20− population consists of basophilic erythroblasts and more
mature nucleated cells of the erythroid lineage.
indicated as: hi=high expression; med=mediate expression; centrifugation and the numbers of granulocytes were deter-
mined by differential count of 200 cells in two Giemsa-stained+=both high and mediate expression, and −=negative
expression. The nomenclature of the bone-marrow cell bone-marrow cytospin preparations.
populations, which are separated on the basis of the intensity
Statistical analysisof antigen expression, after staining the cells with the mono-
The significance of differences between the obtained data wasclonal antibodies ER-MP12 or ER-MP20 and measured by
determined by means of the Student’s t-test. A value ofFACS-analysis (Table 1), are designated as follows: (1) early
P<0·05 was considered significantly different.blasts (ER-MP12hi ER-MP20−) which include of undifferen-
tiated blasts and cells of the myeloid, erythroid and lymphoid
cell-lineages; (2) more differentiated cells of the myeloid cell- RESULTS
lineage (ER-MP12+ ER-MP20+), particularly myeloid blasts
Changes in the relative size of the various murine bone-marrow
either morphologically undifferentiated or recognized as such,
cell populations after cyclophosphamide treatment or irradiation
from which a vast majority of cells expresses the myeloid
in combination with G-CSF treatment
marker Gr-1 (P.J.M. Leenen, unpublished data); (3) granulo-
cytic cells (ER-MP12− ER-MP20med ) including band In naive mice, six different cell populations can be distinguished
(Fig. 1a). At day 4 after cyclophosphamide treatment, theforms and mature granulocytes; (4) Monocytic cells
(ER-MP12− ER-MP20 hi), which contains mainly monocyte relative size of both early and myeloid blast-cell populations
was enlarged and that of the granulocytic cell population wasprecursors and mature monocytes; (5) lymphoid cells
(ER-MP12med ER-MP20−), which contains predominantly markedly reduced (Fig. 1b) compared to that found in the
bone marrow of naive mice (Fig. 1a). After having adminis-mature lymphocytes and a few undifferentiated blasts; and (6)
erythroid cells (ER-MP12− ER-MP20−) consisting of erythro- tered G-CSF to cyclophosphamide-treated mice during 4 days,
the relative size of the mixed blast population was much larger,blasts and more mature nucleated cells of the erythroid cell-
lineage. that of the granulocytic cell population was similar and that
of the monocytic cells was strongly diminished in the bone
marrow (Fig. 1c) compared to those in the bone marrow ofBone marrow culture
Nucleated bone-marrow cells were plated in triplicate at a cyclophosphamide-treated mice not given G-CSF (Fig. 1b).
At day 4 after irradiation, the relative size of all cellconcentration of 1×104 cells per well in a 96-well plate
(Costar) in 100 ml Methocult GF M3534 (Stemcell populations in the bone marrow had not changed (Fig. 1d)
compared to that found in the bone marrow of naive miceTechnologies Inc., Vancouver, Canada), which stimulates the
growth of granulocyte and macrophage colonies. After 7 days (Fig. 1a). After 4 days G-CSF treatment to irradiated mice,
the relative size of the mixed blast population was much larger,of culture at 37° and 7·5% CO2, the cells were gently dispersed
into a single cell suspension by dilution in PBS and the number whereas the size of the granulocytic cell population, the
monocytic cell population and that of the erythroid cellof cells were counted in a Bürker haemocytometer using Türk’s
solution. Subsequently cell preparations were made by cytospin population in the bone marrow was much reduced (Fig. 1e)
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Figure 1. Two-colour flowcytrometric analysis of bone-marrow cells labeled with ER-MP12 and ER-MP20 from (a) naive mice;
(b) cyclophosphamide-treated mice at day 4; (c) cyclophosphamide-treated mice after 4 days G-CSF administration; (d) irradiated
mice at day 4 and (e) irradiated mice after 4 days G-CSF administration. Indicated in (a): 1. early blasts; 2. myeloid blasts; 3.
granulocytic cells; 4. monocytic cells; 5. lymphoid cells; and 6. erythroid cells. FACS-windows of one representative experiment
are indicated.
compared to the respective cell populations in the bone marrow of the other cell populations in the bone marrow were not
significantly affected (data not shown).of irradiated mice not given G-CSF (Fig. 1d).
After irradiation, the total number of bone-marrow cells
decreased from 1·9×108 cells before irradiation to 2·4×107
Effect of G-CSF on the total number of cells in the various bone-
cells at day 1 and to 2·5×107 cells at day 4 after irradiation,
marrow cell populations of cyclophosphamide-treated or
i.e. a eight-fold reduction. The total number of granulocytic
irradiated mice
cells in the bone marrow had decreased threefold and the
number of the other cell populations had decreased four- toThe number of cells in each bone-marrow cell population
in mice was calculated at different time-points after cyclo- 40-fold at day 1 after irradiation (Fig. 2c). Although the
number of granulocytic cells increased at day 7 and decreasedphosphamide treatment or irradiation, whether or not com-
bined with G-CSF-treatment. Cyclophosphamide treatment again at day 11, the numbers of the other cell populations
changed hardly until day 11 after irradiation (Fig. 2c). G-CSFdecreased the total number of cells in the bone marrow from
1·65×108 cells before treatment to 4·4×107 cells at day 1 and administration to irradiated mice increased the number of
myeloid blasts in the bone marrow slightly, but did not affectto 1·5×107 cells at day 4, i.e. a 10-fold reduction. The number
of early blasts hardly changed during 5 days of cyclophos- the numbers of any of the various cell populations of the bone
marrow (data not shown).phamide treatment (Fig. 2a). The numbers of myeloid blasts
and granulocytic cells had decreased strikingly at day 1
(Fig. 2a), reaching nadir numbers at day 3, and increased
Effect of bacterial infection on the total number of cells of the
again after day 3 for the myeloid blasts and after day 4 for
various bone-marrow populations in cyclophosphamide-treated
the granulocytic cells. The number of monocytic cells decreased
or irradiated mice, either treated or not treated with G-CSF
also, reaching low numbers at day 2, followed by a small
increase after day 4 (Fig. 2a). The number of lymphoid cells In cyclophosphamide-treated mice, the total number of bone-
marrow cells did not change during the first 4 hr of infectionin the bone marrow decreased from 4·8×107 cells before
treatment to 1·0×107 cells at day 1 and to 3×106 at day 4 and increased significantly during the next 20 hr. However, a
similar result was found in 24 hr non-infected mice. G-CSF-after cyclophosphamide treatment.
After G-CSF administration to cyclophosphamide-treated treatment increased the total number of cells in the bone
marrow of cyclophosphamide-treated mice (P<0·01); duringmice, the number of early blasts increased slightly and the
number of myeloid blasts increased strikingly (P<0·01) after infection in these mice only a slight increase in the total
number of bone-marrow cells was found, relative to that inday 2 of G-CSF administration (Fig. 2b), whereas the numbers
© 1999 Blackwell Science Ltd, Immunology, 97, 601–610
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Figure 2. Number of bone-marrow cells at different time-intervals after (a) s.c. treatment with 250 mg/kg cyclophosphamide (b)
after sc. treatment with cyclophosphamide followed by G-CSF administration during 4 days, and (c) after sublethal
irradiation.Numbers of early blasts (2), myeloid blasts (&), granulocytic cells (c) and monocytic cells (#) are presented.
n=4–8 mice at each time-point.*=significant difference comparing G-CSF treated mice with non-G-CSF-treated mice
non-infected, G-CSF-treated mice (Fig. 3a). During infection number of granulocytic cells (Fig. 3d), and monocytic cells
(Fig. 3e) increased, but this increase was similar to that inin irradiated mice, whether or not treated with G-CSF, the
total number of bone-marrow cells did not change (Fig. 3a). non-infected G-CSF treated mice.
In irradiated mice, the number of granulocytic cellsThe total number of bone-marrow cells of cyclophospham-
ide-treated or irradiated mice (Fig. 3a), whether or not, treated (Fig. 3d) and monocytic cells (Fig. 3e) decreased during infec-
tion. G-CSF-treatment of irradiated mice increased the numberwith G-CSF and/or infected with S. aureus, and the relative
size of the various bone-marrow cell populations (data not of myeloid blasts (P<0·01) (Fig. 3c); however, an infection in
these mice did not change the number of any of the bone-shown) of these mice were used to calculate the total number
of early blasts (Fig. 3b), myeloid blasts (Fig. 3c), granulocytic marrow cell populations.
cells (Fig. 3d) and monocytic cells (Fig. 3e) in the bone marrow.
During a S. aureus infection in cyclophosphamide-treated
Proliferation of bone-marrow cells in culture
mice the number of myeloid blasts (Fig. 3c) increased and the
number of monocytic cells (Fig. 3e) decreased; in these mice To study whether the repopulating ability of the bone-marrow
cells is affected by cyclophosphamide treatment, irradiation,also the number of early blasts (Fig. 3b) and granulocytic cells
(Fig. 3d) increased significantly, however, a similar result was G-CSF-treatment and/or bacterial infection, bone-marrow
cells of all these mice under study were cultured in vitro. Bone-found in 24 hr non-infected cyclophosphamide-treated mice.
G-CSF-treatment of cyclophosphamide-treated mice increased marrow cells from cyclophosphamide-treated, noninfected
mice, had a significantly higher proliferative activity in culture,the number of early blasts (Fig. 3b), myeloid blasts (Fig. 3c)
(P<0·01) and granulocytic cells (Fig. 3d), and decreased the relative to those of naive mice (Table 2). When cyclophos-
phamide-treated mice were treated with G-CSF, whether ornumber of monocytic cells (Fig. 3e). During infection after
G-CSF administration to cyclophosphamide-treated mice, the not infected with S. aureus, their bone-marrow cells prolifer-
ated significantly more in comparison with those from non-number of early blasts decreased (Fig. 3b), whereas the
© 1999 Blackwell Science Ltd, Immunology, 97, 601–610
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Figure 3. Number of (a) total cells; (b) early blasts; (c) myeloid blasts; (d) granulocytic cells and (e) monocytic cells in the bone
marrow from naive, cyclophosphamide-treated mice or irradiated mice whether or not treated with G-CSF; before infection, at 4
and 24 hr after infection with S. aureus, and 24 hr later without infection in these mice. Mice were treated with cyclophosphamide
or irradiated, thereafter treated with G-CSF or vehicle for 4 days and subsequently infected with 5×106 bacteria in the thigh
muscle; control mice were not infected and studied 24 hr later. Values are mean and sd of 4–10 mice at each time-point. **significant
difference comparing G-CSF-treated with non-G-CSF-treated (P<0·01); *significant difference comparing G-CSF-treated with
non-G-CSF-treated (P<0·05); †significant difference relative to naive mice (P<0·05).
G-CSF, similarly treated, mice (Table 2). The proliferation of of bone-marrow cells, but, when G-CSF-treated, irradiated,
mice were infected for 24 hr, their bone-marrow cells did notbone-marrow cells from S. aureus infected, cylophosphamide-
treated mice, was lower than that of non-infected cyclophos- proliferate (Table 2).
Because the percentages of granulocytes in the bone-phamide-treated mice independent of G-CSF treatment
(Table 2). marrow cultures from all mice under study were about similar
(Table 2), the differences in the total number of granulocytesBone-marrow cells from irradiated mice, whether or not
infected with S. aureus, hardly showed any proliferation during in bone-marrow cell cultures obtained from mice under various
experimental conditions showed the same variations as the7 days of culture (Table 2). However, G-CSF-treatment of
irradiated mice resulted in a significant increased proliferation total number of cells after 7 days of culture (Table 2).
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Figure 3. (Continued )
Table 2. Proliferation of bone-marrow cells from naive, cyclophosphamide-treated and irradiated mice treated with G-CSF and infected with S.
aureus†
Time after Total number of Total number
infection cells after 7 days Percentage of of granulocytes
Mice G-CSF (h) (×104) granulocytes‡ (×104)‡
Naive − 0 12·5 (3·5) 33·3 (10·7) 4·9 (2·3)
− 4 24·3 (24·8) 32·5 (5·5) 1·8 (1·6)
− 24 15·5 (9·9) 20·2 (2·8) 3·1 (2·0)
Cyclophosphamide-treated − 0 51·0 (1·1)§ 30·5 (2·8) 16·0 (0·8)§
+ 0 110·7 (24·5)** 28·7 (10·7) 33·1 (17·4)**
− 4 15·1 (3·5) 20·5 (0·5) 3·1 (0·7)
+ 4 118·0 (10·5)** 23·0 (5·1) 27·4 (8·0)**
− 24 25·4 (8·7) 24·2 (6·2) 6·7 (4·2)
+ 24 40·0 (10·4) 22·5 (2·7) 9·0 (2·4)
Irradiated − 0 1·2 (0·7)§ 20·8 (5·6) 0·2 (0·1)§
+ 0 7·3 (5·2)* 24·2 (3·5) 1·6 (0·9)*
− 4 1·3 (0·7)§ 22·2 (5·7) 0·3 (0·1)§
+ 4 6·0 (3·1)* 25·7 (1·1) 1·5 (0·8)*
− 24 1·8 (1·9) 19·0 (6·1) 0·4 (0·5)
+ 24 1·4 (0·4) 27·7 (2·1) 0·4 (0·1)
†Mice were treated with cyclophosphamide or irradiated, then treated with G-CSF or vehicle for 4 days and subsequently either or not
infected with 5×106 S. aureus in the thigh muscle. Before infection and at 4 and 24 hr after infection, bone-marrow cells from the mice were
isolated and 1×104 bone marrow were cultured for 7 days in triplicate, then the total number of cells present and the number of granulocytes
were determined. values are mean (SD) of three mice at each time-point.
‡After 7 days of culture granulocyte precursors are differentiated into mature granulocytes.
§Significant difference relative to naive mice (P<0·05).
**Significant difference comparing G-CSF-treated with non-G-CSF-treated (P<0·01).
*Significant difference comparing G-CSF-treated with non-G-CSF-treated; (P<0·05).
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Effect of G-CSF on the number of granulocytes in peri- increased number of granulocyte precursors in the bone
marrow, which can not be identified as a separate class of cellspheral blood of cyclophosphamide or irradiated mice whether
or not infected with S. aureus. with the monoclonal antibodies used. Ultimately this results
in a large increase in the number of mature granulocytes,After cyclophosphamide treatment, the number of circulat-
ing granulocytes reached nadir values at day 4 (Fig. 4), which including band forms, in the circulation. However, in irradiated
mice, whether or not infected, G-CSF increased only slightlyremained unchanged at day 5 (data not shown). During
infection of cyclophosphamide-treated mice, the number of the number of myeloid blasts and did not affect the number
of circulating granulocytes. The results of the present studyblood granulocytes had not changed at 4 hr, but increased
(P<0·05) during the next 20 hr, relative to non-infected mice. are in agreement with our earlier study demonstrating no
effect of G-CSF treatment on the course of a S. aureusG-CSF administration to cyclophosphamide-treated mice
increased the number of circulating granulocytes (P<0·05) infection of the thigh muscle in sublethally irradiated mice,
while in cyclophosphamide-treated mice, that had been admin-(Fig. 4). In cyclophosphamide-treated, infected mice, which
were treated with G-CSF, the number of circulating granulo- istered G-CSF, the elimination of bacteria in thigh muscle,
spleen and liver was significantly faster compared to non-G-cytes increased 10-fold (P<0·01) at 24 hr compared to non-
infected, similarly treated mice (Fig. 4). CSF similarly treated mice.4 The results of these in vivo studies
are supported by in vitro cultures of bone-marrow cells of theIn irradiated mice, the number of circulating granulocytes
reached low values at 4 days and during infection the number mice under the various experimental conditions applied. The
most striking difference was that in cultures of bone-marrowof blood granulocytes did not change (Fig. 4). G-CSF treat-
ment of irradiated mice did not affect the number of granulo- cells from cyclophosphamide-treated, S. aureus-infected mice,
that had received G-CSF, the proliferation of granulocytecytes in the peripheral blood (Fig. 4).
precursors resulting in mature granulocytes, was many-fold
greater than in sublethally irradiated, similarly treated mice.
DISCUSSION
When we speculate about the differences in response to
G-CSF treatment between cyclophosphamide-treated andIn the present study we focused on the stimulatory effects of
G-CSF on various bone-marrow cell populations of granulocy- irradiated mice, we may assume that in the bone marrow of
cyclophosphamide-treated mice G-CSF-responsive cells aretopenic mice, whether or not infected with S. aureus.
Differences were found between mice rendered granulo- still present, while in irradiated mice these cells can not respond
any more or have been eliminated. The difference in responsecytopenic by cyclophosphamide treatment or by sublethal
irradiation. The main conclusions that could be drawn from to G-CSF between cyclophosphamide-treated and irradiated
mice can not be explained by a difference in the degree ofthese studies are that cyclophosphamide treatment spares the
early blast population but affects the other cell populations in granulocytopenia; granulocytopenia was even more severe
in the cyclophosphamide-treated mice compared to thethe bone marrow, whereas sublethal irradiation affects all
bone-marrow cell populations. irradiated mice.
Sublethal irradiation of naive mice damaged all subpopula-When we consider cyclophosphamide-treated, non-infected
mice, G-CSF increased both the number of early and to a tions of the bone marrow, including the early blasts. Irradiation
affects only active cycling cells during DNA-synthesis11 andgreater extent, the number of myeloid blasts. During an S.
aureus infection in these mice, the number of the myeloid the recovery after irradiation is influenced primarily by the





































Figure 4. Number of granulocytes in peripheral blood of naive, cyclophosphamide-treated mice and irradiated mice whether or
not treated with G-CSF before infection and at 4 and 24 hr after infection with S. aureus in these mice. Mice were treated with
cyclophosphamide or irradiated, thereafter treated with G-CSF or vehicle for 4 days and subsequently infected with 5×106 bacteria
in the thigh muscle. Values are mean and sd of 4–10 mice at each time-point. **significant difference comparing G-CSF-treated
with non-G-CSF-treated (P<0·01); *significant difference comparing G-CSF-treated with non-G-CSF-treated (P<0·05); †signifi-
cant different relative to naive mice (P<0·05).
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bone-marrow cells in the S-phase of cell cycle are more radio- production of granulocyte precursor cells in the bone marrow
induced by G-CSF, because the number of early and myeloidresistant than other cells.16 In our experiments, cultures of
bone-marrow cells from irradiated mice, whether or not treated blasts blasts in the bone marrow of G-CSF-treated mice was
about two times higher in comparison with that in the bonewith G-CSF, did not show any substantial increase, but also
no decrease in cell number, which indicates that a great marrow of non-G-CSF-treated, cyclophosphamide-treated
mice. However, an increase of immature circulating granulo-majority of dividing cells, probably cells not in S-phase, are
affected by irradiation. cytes after cyclophosphamide treatment, whether or not
combined with G-CSF administration, has been reportedApparently, in vivo, the delay of bone-marrow recovery
exhibited by the increase in the numbers of bone-marrow cells recently.24–26 The mechanisms underlying the mobilization
of mature and immature cells from bone marrow into theand circulating granulocytes after G-CSF treatment differed
also between irradiated and cyclophosphamide-treated mice. circulation are unknown as yet.
After irradiation and G-CSF treatment bone-marrow recovery
did not occur during the first 11 days, while after cyclophos-
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